November 1, 2016
Researchers at University of California San Diego School of Medicine and Mayo Clinic provide the first evidence that the Hedgehog signaling pathway is central to the formation of gastrointestinal stromal tumors (GIST), which are frequently driven by the KIT oncogene.
December 15, 2016
In recent years, researchers have identified specific gene mutations linked to gastrointestinal stromal tumors (GIST), which primarily occur in the stomach or small intestine, but 10 to 15 percent of adult GIST cases and most pediatric cases lack the tell-tale mutations, making identification and treatment difficult. Researchers at University of…
January 18, 2017
Gastrointestinal stromal tumors (GIST) are tumors that arise is the wall of the digestive tract, and most often occur in the stomach or small intestine. Though more common in later in life, GISTs can occur in adolescents and young adults (AYA) under 40 years old as well. Researchers at the…
August 27, 2018
Researchers at University of California San Diego School of Medicine have launched a phase Ib clinical trial to assess the safety and tolerability of cirmtuzumab, in combination with standard chemotherapy, to treat metastatic or locally advanced breast cancer that cannot be surgically removed.
July 2, 2019
Bladder cancer, one of the most common cancers in the U.S., may be soon helped by a novel non-invasive diagnostic method thanks to machine learning research by researchers at UC San Diego’s San Diego Supercomputer Center and Moores Cancer Center.
September 17, 2019
Researchers at the University of California San Diego figured out a way to combine FDA-approved ultrasound with engineered glass particles to boost the effectiveness of immunotherapy in glioblastomas.
November 5, 2019
Of the 3.5 million breast cancer survivors in the US, 1 in 5 will be diagnosed with a painful swelling condition called lymphedema, which can occur as a consequence of lymph nodes being removed. UC San Diego Health now offers a novel surgical procedure to help prevent this debilitating condition.
March 11, 2020
From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages.
August 3, 2020
UC San Diego researchers discovered that people with an inactive RNA-editing enzyme respond better to cancer immunotherapy, and inhibitors of the enzyme help mice with difficult-to-treat cancers live longer.
September 21, 2020
Moores Cancer Center at UC San Diego Health is using advanced imaging, genomics, personalized medicine and new therapies to treat patients like Brian McCloskey, who has stage IV prostate cancer.
